Botulinum toxin treatment in parkinsonism.
Abstract
Botulinum toxin (BoNT) was approved by the United States Food and Drug Administration (FDA) in 1989 for facial movement disorders and strabismus, but since that time its indications have been expanding beyond neurologic and ophthalmologic disorders. This article is a narrative review of the therapeutic use of BoNT in tremors, dystonia, sialorrhea, bladder and other autonomic symptoms, levodopa-induced dyskinesia and other problems occuring in the setting of parkinsonism. Though FDA approval is lacking for some of these indications, expert experiences have shown that BoNT is often beneficial in this group of patients.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | bladder
|
scispacy | 1 | ||
| 약물 | BoNT
→ Botulinum toxin
|
C0006055
Botulinum Toxins
|
scispacy | 1 | |
| 약물 | FDA
→ Food and Drug Administration
|
scispacy | 1 | ||
| 질환 | parkinsonism
|
C0242422
Parkinsonian Disorders
|
scispacy | 1 | |
| 질환 | strabismus
|
C0038379
Strabismus
|
scispacy | 1 | |
| 질환 | tremors
|
C0040822
Tremor
|
scispacy | 1 | |
| 질환 | dystonia
|
C0013421
Dystonia
|
scispacy | 1 | |
| 질환 | sialorrhea
|
C0037036
Sialorrhea
|
scispacy | 1 | |
| 질환 | dyskinesia
|
C0013384
Dyskinetic syndrome
|
scispacy | 1 | |
| 기타 | BoNT
→ Botulinum toxin
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 |
MeSH Terms
United States; Humans; Botulinum Toxins; Parkinson Disease; Parkinsonian Disorders; Tremor; Dystonic Disorders; Botulinum Toxins, Type A
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.